A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

BACKGROUND: Sarcomas are a rare, heterogeneous group of tumors with variable tendencies for aggressive behavior. Molecular markers for prognosis are needed to risk stratify patients and identify those who might benefit from more intensive therapeutic strategies. PATIENTS AND METHODS: We analyzed som...

Descripción completa

Detalles Bibliográficos
Autores principales: Bui, Nam Q., Przybyl, Joanna, Trabucco, Sally E., Frampton, Garrett, Hastie, Trevor, van de Rijn, Matt, Ganjoo, Kristen N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739971/
https://www.ncbi.nlm.nih.gov/pubmed/31528332
http://dx.doi.org/10.1186/s13569-019-0122-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739971/
https://www.ncbi.nlm.nih.gov/pubmed/31528332
http://dx.doi.org/10.1186/s13569-019-0122-5

Ejemplares similares